MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹333 Cr | ₹241 Cr | ₹290 Cr | ₹167 Cr | ₹138 Cr |
What is the latest Total Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹290 Cr |
| Mar2022 | ₹167 Cr |
| Mar2021 | ₹138 Cr |
How is Total Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹333 Cr | 38.03 | |
| Mar2024 | ₹241 Cr | -16.89 | |
| Mar2023 | ₹290 Cr | 74.27 | |
| Mar2022 | ₹167 Cr | 20.76 | |
| Mar2021 | ₹138 Cr | - | |
Compare Total Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹527.4 Cr | -2.4% | 22.5% | 13.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,785.9 Cr | 8% | 1.6% | -27.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,010.7 Cr | 0.8% | -4.8% | -9.5% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,057.0 Cr | -3.8% | 2.7% | 10% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹970.7 Cr | -1.6% | -5.8% | NA | Stock Analytics | |
| NATH BIOGENES (INDIA) | ₹318.9 Cr | 0.4% | -2.3% | -17.1% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -2.4% |
22.5% |
13.1% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses